Skip to main content
. 2020 Apr 27;19(1):1–5. doi: 10.5114/pm.2020.95293

Table 1.

Age, body mass index, and hormonal profile of the two studied groups

Variable PCOS women (study group)
(n = 119)
Non-PCOS controls
(n = 118)
p-value
(95% CI)
Age (years) 24.2 ±3.6 26.3 ±5.4 0.9 (–3.3, –2.1, –0.9)
BMI (kg/m<sup>2</sup>) 30.7 ±6.0 24.5 ±4.5 0.001* (4.8, 6.2, 7.6)
FSH (mIU/ml) 6.5 ±4.6 5.3 ±4.3 0.2 (0.06, 1.2, 2.3)
LH (mIU/ml) 18.7 ±7.5 5.9 ±6.2 0.02* (11, 12.8, 14.6)
LH/FSH ratio 2.8 ±3.3 1.1 ±2.7 0.01* (0.9, 1.7, 2.5)
Total testosterone (ng/dl) 92.5 ±9.1 44.3 ±6.9 0.001* (46.1, 48.2, 50.3)
Free testosterone (pg/ml) 5.7 ±3.6 2.5 ±2.8 0.003* (2.4, 3.2, 4.03)
Androstenedione (ng/ml) 4.2 ±2.9 2.3 ±2.4 0.02* (1.22, 1.9, 2.58)
DHEA (ng/l) 8937 ±2.9 5491 ±3.7 0.99 (3445.1, 345, 3446.9)

BMI – body mass index, FSH – follicle stimulating hormone, LH – luteinising hormone, DHEA – dehydroepiandrosterone (normal 1330-7780 ng/l), PCOS – polycystic ovary syndrome, CI – confidence interval. Total testosterone normal value 6-86 ng/dl, free testosterone normal value 0.7-3.6 pg/ml, androstenedione normal value 0.7-3.1 ng/ml. Student’s t-test used for statistical analysis. * Significant difference. Data presented as mean ±standard deviation (SD)